A few weeks ago, we gathered together for the CHARM Therapeutics summer event. This was made even more special as we marked the opening of our new lab at the Babraham Research Campus. The atmosphere was electric, filled with the excitement of our growth and the anticipation of a bright future ahead! 🚀 🚀 🚀 #biotechnology #drugdiscovery #deeplearning
CHARM Therapeutics
Research Services
Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients.
About us
CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients.
- Website
-
www.charmtx.com
External link for CHARM Therapeutics
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
London, GB
-
Cambridge, GB
Employees at CHARM Therapeutics
Updates
-
I’m very much looking forward to attending and speaking at #PepTalk2025 In January in #SanDiego! Join me for my talk on methods for in vivo protein biotinylation in the Recombinant Protein Production Part 1 track, where I’ll also be Chairing a session and hosting a BuzZ roundtable discussion on post-translational modifications in recombinant protein production #biotechnology #proteins https://lnkd.in/ea-Pp8qF
-
CHARM Therapeutics is #hiring! We are seeking a true HR generalist motivated to take responsibility for the full HR remit as our People Manager. Reporting to Laura Hare, our Chief People Officer, the role offers flexibility and variety, partnering with CHARM's wider team to achieve cutting edge scientific and technological innovation. Find out more about this position and apply below.
-
CHARM Therapeutics is #hiring! We’re looking for an experienced Biology leader with an oncology focus and a passion for scientific innovation to join our multidisciplinary team of drug discovery scientists as Head of Biology. Find out more about this position and apply online through the link below.
-
CHARM scientists Abigail Mornement, Amanda Kennedy and Charlotte Barrett are in Barcelona for this year’s EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics, commonly known as the "triple meeting”. This meeting is a great opportunity to connect with other scientists and industry leaders and will allow engaging discussions on the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology. To learn more: https://lnkd.in/eb6tKDZE #ai #drugdiscovery #cancer #oncology #triplemeeting
-
Our Machine Learning Engineering Manager, Liam Atkinson, is attending the BioIndustry Association (BIA) #TechBioUK conference taking place today in Kings Place, London. He’s looking forward to hearing about how cutting-edge machine learning techniques are being used to solve drug discovery and R&D challenges. To learn more: https://lnkd.in/eRB4eJBH #oncology #cancer #drugdiscovery #deeplearning #AI
-
CHARM Therapeutics reposted this
We are immensely proud to announce that our Scientific Co-Founder, Prof. David Baker, has been awarded the 2024 Nobel Prize in Chemistry. Since 2003, Prof. Baker has pioneered the design of novel proteins, creating spectacular protein structures with applications in pharmaceuticals, vaccines, nanomaterials, and sensors. As the Nobel Academy noted, "Life could not exist without proteins. That we can now predict protein structures and design our own proteins confers the greatest benefit to humankind." We extend our warmest congratulations to Prof. Baker on this extraordinary achievement and look forward to the continued impact of his research. https://lnkd.in/eknNuN4C #oncology #cancer #drugdiscovery #deeplearning #AI
-
We are immensely proud to announce that our Scientific Co-Founder, Prof. David Baker, has been awarded the 2024 Nobel Prize in Chemistry. Since 2003, Prof. Baker has pioneered the design of novel proteins, creating spectacular protein structures with applications in pharmaceuticals, vaccines, nanomaterials, and sensors. As the Nobel Academy noted, "Life could not exist without proteins. That we can now predict protein structures and design our own proteins confers the greatest benefit to humankind." We extend our warmest congratulations to Prof. Baker on this extraordinary achievement and look forward to the continued impact of his research. https://lnkd.in/eknNuN4C #oncology #cancer #drugdiscovery #deeplearning #AI
-
Fantastic to see that CHARM Therapeutics has been recognised as one of the top emerging startups in life sciences technology by Tracxn. #oncology #cancer #drugdiscovery #deeplearning #AI
Tracxn is proud to publish the next #EmergingStartups series. Have a look at the "Emerging Startups 2024: Top Life Sciences Tech Startups" covering the most promising startups in this space, from across the globe. (https://lnkd.in/gvtkkM7s) #emergingtech #technology #startups #soonicorns #unicorn
-
Can AI Solve the Molecule Mysteries that will Unlock Simpler Drug Discovery? In the latest episode of RBC Capital Markets’ Pathfinders in Biopharma podcast, our CEO, Laksh Aithani, joins host Noël Brown and Clarissa Desjardins, CEO at Congruence Therapeutics, to answer this exciting question. In this discussion, Laksh shared insights on AI's role in decoding protein-molecule binding. Tune in to explore the cutting-edge intersection of AI and drug discovery. Listen now: https://lnkd.in/eJBMwHFc #drugdiscovery #deeplearning #AI #podcast